Endo Pharmaceuticals, Inc. (Nasdaq:ENDO) is a biotechnology company that manufactures and sells products for the treatment of cancer. The company’s products are used in a variety of medical treatments, including chemotherapy, radiation therapy, and surgery. Endo’s stock is currently worth $5.14 per share on the PS4 market.
